endex 8.75% w/v oral suspension for sheep
novartis animal health uk ltd - triclabendazole, levamisole hydrochloride - oral suspension - 8.75 %w/v - combinations of benzimidazoles and related substances - ovine - endoparasiticide
endex 8.75% w/v oral suspension for sheep
elanco europe ltd - triclabendazole, levamisole hydrochloride - oral suspension - 8.75 %w/v - combinations of benzimidazoles and related substances - ovine - endoparasiticide
endex 8.75 % w/v oral suspension for sheep
elanco europe ltd - triclabendazole, levamisole hydrochloride - oral suspension - 8.75 percent weight/volume - combinations of benzimidazoles and related substances - sheep - endoparasiticide
fasinex super 19.5% w/v oral suspension
elanco europe ltd - triclabendazole, levamisole hydrochloride - oral suspension - 19.5 percent weight/volume - anthelmintics - cattle - endoparasiticide
fasinex super 19.5% w/v oral suspension
elanco gmbh - triclabendazole; levamisole hydrochloride - oral suspension - 19.5 percent weight/volume - anthelmintics - cattle - endoparasiticide
endex 8.75 % w/v oral suspension for sheep
elanco gmbh - triclabendazole; levamisole hydrochloride - oral suspension - 8.75 percent weight/volume - combinations of benzimidazoles and related substances
endex 19.5 % w/v oral suspension for cattle
novartis animal health uk ltd - triclabendazole, levamisole hydrochloride - oral suspension - 19.5 %w/v - combinations of benzimidazoles and related substances - bovine - endoparasiticide
endex 19.5 % w/v oral suspension for cattle
elanco europe ltd - triclabendazole, levamisole hydrochloride - oral suspension - 19.5 %w/v - combinations of benzimidazoles and related substances - bovine - endoparasiticide
endex 19.5 % w/v oral suspension for cattle
elanco europe ltd - triclabendazole, levamisole hydrochloride - oral suspension - 19.5 percent weight/volume - combinations of benzimidazoles and related substances - cattle - endoparasiticide
endex 19.5 % w/v oral suspension for cattle
elanco gmbh - triclabendazole; levamisole hydrochloride - oral suspension - 19.5 percent weight/volume - combinations of benzimidazoles and related substances